trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Reperfusion Injury D015427 65 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Translocation, Genetic D014178 20 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Osteosarcoma D012516 50 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Retinoblastoma D012175 12 associated lipids
Radiation Injuries D011832 14 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Progeria D011371 3 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Osteomalacia D010018 5 associated lipids
Neuroblastoma D009447 66 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neoplasms D009369 13 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Nasal Polyps D009298 26 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Intellectual Disability D008607 13 associated lipids
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukemia D007938 74 associated lipids
Leishmaniasis D007896 19 associated lipids
Keloid D007627 12 associated lipids
Chromosome Inversion D007446 1 associated lipids
Inflammation D007249 119 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Hypesthesia D006987 1 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Toscano MG et al. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells. 2015 Mol. Ther. pmid:25292191
Hou H et al. Influence of intra-articular administration of trichostatin a on autologous osteochondral transplantation in a rabbit model. 2015 Biomed Res Int pmid:25866784
Guo W et al. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma. 2015 Clin. Exp. Metastasis pmid:25579665
Kitchen MO et al. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells. 2015 Pituitary pmid:25557289
Tiernan AR et al. Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells. 2015 Exp. Cell Res. pmid:25305500
Schlörmann W et al. Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells. 2015 Genes Nutr pmid:26559563
Sugimoto H et al. Production of somatic cell nuclear transfer embryos using in vitro-grown and in vitro-matured oocytes in rabbits. 2015 Zygote pmid:24666637
Singh AK et al. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer. 2015 Clin. Cancer Res. pmid:26130461
Lee YR et al. Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation. 2015 Oncotarget pmid:26125438
Lim SY et al. Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A. 2016 Methods Mol. Biol. pmid:25520285
Dai Q et al. Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro. 2016 Acta Pharmacol. Sin. pmid:26775659
Rong X et al. Effects of histone acetylation on superoxide dismutase 1 gene expression in the pathogenesis of senile cataract. 2016 Sci Rep pmid:27703255
Zhang Y and Zhang B Trichostatin A, an Inhibitor of Histone Deacetylase, Inhibits the Viability and Invasiveness of Hypoxic Rheumatoid Arthritis Fibroblast-Like Synoviocytes via PI3K/Akt Signaling. 2016 J. Biochem. Mol. Toxicol. pmid:26509796
Contreras-Leal E et al. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines. 2016 Mol. Carcinog. pmid:26331238
Bricambert J et al. Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function. 2016 Mol Metab pmid:27900262
Kim HR et al. Aberrant Expression of TIMP-2 and PBEF Genes in the Placentae of Cloned Mice Due to Epigenetic Reprogramming Error. 2016 PLoS ONE pmid:27855185
Tombolan L et al. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma. 2016 BMC Cancer pmid:27842508
Tao W et al. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain. 2016 Neuroscience pmid:27646288
Chen W et al. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation. 2016 Biochim. Biophys. Acta pmid:27638301
Bauer I et al. A Class 1 Histone Deacetylase with Potential as an Antifungal Target. 2016 MBio pmid:27803184
Xu Q et al. Changes in cardiac Nav1.5 expression, function, and acetylation by pan-histone deacetylase inhibitors. 2016 Am. J. Physiol. Heart Circ. Physiol. pmid:27638876
Nadanaka S et al. Histone deacetylase-mediated regulation of chondroitin 4-O-sulfotransferase-1 (Chst11) gene expression by Wnt/β-catenin signaling. 2016 Biochem. Biophys. Res. Commun. pmid:27751852
Tiper IV and Webb TJ Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma. 2016 Cancer Immunol. Immunother. pmid:27614429
Morinobu A et al. Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts. 2016 PLoS ONE pmid:27736946
Li C et al. PU.1-Bim axis is involved in Trichostatin A-induced apoptosis in murine pro-B lymphoma FL5.12 cells. 2016 Acta Biochim. Biophys. Sin. (Shanghai) pmid:27451443
Igaz N et al. Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles. 2016 Colloids Surf B Biointerfaces pmid:27434153
Qu H et al. Trichostatin A increases the TIMP-1/MMP ratio to protect against osteoarthritis in an animal model of the disease. 2016 Mol Med Rep pmid:27431944
Choi SY et al. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. 2016 J. Cell. Mol. Med. pmid:27420561
Dhoke NR et al. Histone deacetylases differentially regulate the proliferative phenotype of mouse bone marrow stromal and hematopoietic stem/progenitor cells. 2016 Stem Cell Res pmid:27394013
Drzewiecka H et al. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers. 2016 J. Cancer Res. Clin. Oncol. pmid:27393180
Zhang NH et al. Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells. 2016 Oncol. Rep. pmid:27373420
Chang I and Wang CY Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy. 2016 J. Biol. Chem. pmid:27369083
Yagi K et al. Histone Deacetylase Inhibition Protects Mice Against Lethal Postinfluenza Pneumococcal Infection. 2016 Crit. Care Med. pmid:27352127
Wei L et al. Microinjection of histone deacetylase inhibitor into the ventrolateral orbital cortex potentiates morphine induced behavioral sensitization. 2016 Brain Res. pmid:27312092
Hakami NY et al. Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis. 2016 J. Cell. Mol. Med. pmid:27297729
Raju I et al. Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells. 2016 Biol. Chem. pmid:27279059
Cui W et al. A SUMO-acetyl switch in PXR biology. 2016 Biochim. Biophys. Acta pmid:26883953
Ma X et al. Identification of genes regulated by histone acetylation during root development in Populus trichocarpa. 2016 BMC Genomics pmid:26847576
Li L et al. Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer. 2016 Tumour Biol. pmid:26831669
Rios EC et al. The role of nitric oxide in the epigenetic regulation of THP-1 induced by lipopolysaccharide. 2016 Life Sci. pmid:26826317
Wang X et al. The synergistic effect of 5Azadc and TSA on maintenance of pluripotency of chicken ESCs by overexpression of NANOG gene. 2016 In Vitro Cell. Dev. Biol. Anim. pmid:26822431
Kuan CS et al. Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells. 2016 PLoS ONE pmid:26807725
Noh H et al. Trichostatin A enhances estrogen receptor-alpha repression in MCF-7 breast cancer cells under hypoxia. 2016 Biochem. Biophys. Res. Commun. pmid:26768368
Hosseini SM et al. Epigenetic modification with trichostatin A does not correct specific errors of somatic cell nuclear transfer at the transcriptomic level; highlighting the non-random nature of oocyte-mediated reprogramming errors. 2016 BMC Genomics pmid:26725231
Lee K et al. Histone deacetylation-mediated cellular dedifferentiation in Arabidopsis. 2016 J. Plant Physiol. pmid:26724747
Calvert S et al. A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans. 2016 Aging Cell pmid:26676933
Saini M et al. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos. 2016 Reprod. Fertil. Dev. pmid:25409339
Trifunović D et al. HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo. 2016 Hum. Mol. Genet. pmid:28172811
Kim HJ et al. Enhancement of human mesenchymal stem cell differentiation by combination treatment with 5-azacytidine and trichostatin A. 2016 Biotechnol. Lett. pmid:26341652
Meng Z et al. PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition. 2016 Oncogene pmid:26279303